BETTERLIFE PHARMA INC. Revenue From Interest
BETTERLIFE PHARMA INC. (BETRF) reported Revenue From Interest of CAD 265 for the 12-month period ending 2021-01-31, per its 20-F/A filed 2023-06-06.
Discontinued › Income Statement › Other Income
ifrs-full:RevenueFromInterest · last filed 2023-06-06
| Period end | Revenue From Interest 12 month |
|---|---|
| 2021-01-31 | 265.00 CAD 20-F/A · filed 2023-06-06 |
| 2020-01-31 | 4.48K CAD 20-F · filed 2022-06-06 |
| 2019-01-31 | 4.20K CAD 20-F/A · filed 2021-06-23 |